Xarelto Lawsuit Update: New Report Suggests Link Between Rivaroxaban and Vitreous Hemorrhaging

July 7, 2015

One month has passed since Lowe Scott Fisher Co., LPA apprised readers of the dangers of Xarelto (Rivaroxaban), and in that brief period a new report has surfaced that could implicate the anti-coagulant in a host of new injury claims.

On June 25, 2015, JAMA Ophthalmology published a Brief Report titled, “Association of Rivaroxaban Anticoagulation and Spontaneous Vitreous Hemorrhage.”  The report references the experiences of patients who were prescribed the anti-coagulant warfarin and were later transitioned to Xarelto.  Following transition to the new prescription, multiple patients suffered vitreous hemorrhages, a type of inner eye bleeding that can cause blurred vision and even vision loss.

Given Xarelto’s dangerous and well-established link to uncontrollable bleeding in patients, instances of vitreous hemorrhage are in line with the risks and injuries at the center of ongoing Xarelto lawsuits.  What is alarming about this report is that suggests that there may be an entire group of individuals suffering the harmful effects of the drug who are unaware of its causal relationship.  Because many individuals who have received Xarelto are senior citizens, vision impairment issues may be attributed to aging or other conditions even though this harmful drug is to blame.

Xarelto Lawsuits are Underway

Xarelto is known to cause numerous side effects, including:

* Uncontrollable bleeding

* Gastrointestinal bleeding

* Headaches

* Dizziness

* Feeling weak

* Stroke, upon stopping medication

* Abnormal liver function

* Death

If you or a loved one were suffered any of these symptoms after taking Xarelto, you may be entitled to compensation.  Contact the law firm of Lowe Scott Fisher Co., LPA now for a free consultation.

Back To Blog